The FDA announced on 2013-11-06 that GlaxoSmithKline LLC voluntarily recalled Sandoz Sumatriptan Succinate Injection due to a lack of assurance of sterility. The hazard involves pre-filled syringes with needles protruding through the needle shield.
How to tell if you have it
- Brand: Sandoz
- Product: Sumatriptan Succinate Injection, 6 mg, 0.5 mL
- NDC: 0781-3173-07
- Lot#: C636242
- Expiration: 06/15
The hazard
A small number of pre-filled syringes may contain needles which protrude through the needle shield, creating a lack of assurance of sterility.
Context
GovInfoNow's records show GlaxoSmithKline LLC has 11 other recalls on record since 2012-10-08. Other recent recalls include labeling errors for Tivicay PD (2024-05-17) and Tivicay Tablets (2022-05-13), as well as failed release testing for ANORO ELLIPTA inhalers (2023-12-12). Similar products recalled recently include Reliance Bortezomib Injection (2026-06-24) and New Life Pharma Semaglutide Injections (2026-02-26), both citing lack of sterility assurance.